Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200030/S026

GORE EXCLUDER Conformable AAA Endoprosthesis

W. L. Gore and Associates, Inc. · Decision date Jul 29, 2026

FDA DECISIONP200030/S026

What did the FDA decide?

FDA records P200030/S026 as a supplement to PMA P200030, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 29, 2026.

FDA approval order statement

removal of UV adhesive application onto the guidewire extension tube via the hypotube assembly during manufacturing of the GORE EXCLUDER Conformable AAA Endoprosthesis
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Jul 29, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P200030/S026
Regulatory pathway
PMA supplement
Product code
MIH
Decision code
OK30
Decision date
Jul 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.

Product code
MIH
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P200030/S022 · Related supplement

    GORE EXCLUDER Conformable AAA Endoprosthesis (EXCC) 00733132650927; 00733132650934; 00733132650941; 00733132650958; 00

  2. P200030/S023 · Related supplement

    GORE EXCLUDER Conformable AAA Endoprosthesis

  3. P200030/S024 · Related supplement

    GORE EXCLUDER Conformable AAA Endoprosthesis

  4. P200030/S025 · Related supplement

    GORE EXCLUDER Conformable AAA Endoprosthesis

  5. P200030/S026 received

    Application receipt date recorded by FDA.

  6. P200030/S026 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P200030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200030

Explore the linked device profile

Other records with product code MIH

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

W. L. Gore and Associates, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
32360 N. N. Valley Pkwy., Phonix, AZ, 85085

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records